Volpara Health Technologies Share Price and Company Fundamentals
Last traded: Last Friday at 6:10 AM
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback for every mammography exam; Volpara Lung, a patient management software that streamlines lung screening workflow, compliance, and reimbursement; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function that calculates volumetric breast density, fibroglandular tissue volume, and breast volume to assign a Volpara Density Grade; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited operates in North America, Europe, the Middle East, Africa, and the APAC countries. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
|Primary activities||Develops digital health solutions to enable personalised breast cancer screening software applications|
|Industry / Sector||Health Information Services / Healthcare|
|Full time employees||175|
|Mailing address||Simpl House Level 14 40 Mercer Street Wellington Central Wellington 6011 New Zealand|
|Phone / Fax||64 4 499 6029 /|
|Share registry||BOARDROOM PTY LIMITED|
Volpara Health Technologies does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Volpara Health Technologies.
|Dr. Ralph Highnam B.Sc., M.Sc., Ph.D.||MD, Chief Scientist, CEO & Director||323.24k|
|Mr. Craig Hadfield||CFO & Company Sec.||218.5k|
|Prof. Nico Karssemeijer||Co-Founder & Member of Scientific Board|
|Mr. Simon Francis||Chief Operating Officer|
|Mr. Gareth Beaumont||Chief Information Officer & Chief Information Security Officer|
|Ms. Jill Spear||Exec. VP of Sales & Marketing|
|Ms. Kathryn Greene||Chief People Officer|
|Mr. Julian Marshall||Chief Knowledge Officer|
|Mr. Mark P. Morris||Exec. VP|
|Matt Prickett||Sr. VP of Product|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Volpara Health Technologies is 314.19M and its enterprise value is 286.92M. The enterprise value to revenue ratio of VHT is 14.53.
The VHT's stocks Beta value is 0.53 making it 47% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Volpara Health Technologies (VHT)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Volpara Health Technologies (ASX:VHT) Frequently Asked Questions
1. What is Volpara Health Technologies's Stock Symbol?
Volpara Health Technologies trades on ASX under the ticker symbol "VHT".
2. What is Volpara Health Technologies's stock price today?
One share of VHT stock can currently be purchased for approximately $1.25.
3. How can I contact Volpara Health Technologies?
Volpara Health Technologies's mailing address is Simpl House Level 14 40 Mercer Street Wellington Central Wellington 6011 New Zealand. The company can be reached via phone at 64 4 499 6029.
4. What is Volpara Health Technologies's official website?
The official website of Volpara Health Technologies is http://volparasolutions.com.
5. Which share registry manages Volpara Health Technologies's stock?
Volpara Health Technologies's stock is managed by BOARDROOM PTY LIMITED.